Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia

Daniela Sepúlveda-Beltran; Alvaro Mondragón-Cardona; Carlos Enrique Conde-Martin; Oscar Alberto Lopez-Guevara; Nubia Rocio Hernandez-Rojas; Mario Alberto Caviedes-Cleves; David E. Gutierrez-Ortega; Carmen R. Rangel-Meza; Franci Karina Conde-Tavera; Alfonso J. Rodriguez-Morales; Kuldeep Dhama

doi:10.18006/2021.9(2).131.137

Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia

Daniela Sepúlveda-Beltran, Alvaro Mondragón-Cardona, Carlos Enrique Conde-Martin, Oscar Alberto Lopez-Guevara, Nubia Rocio Hernandez-Rojas, Mario Alberto Caviedes-Cleves, David E. Gutierrez-Ortega, Carmen R. Rangel-Meza, Franci Karina Conde-Tavera, Alfonso J. Rodriguez-Morales, Kuldeep Dhama

Research output: Contribution to journal › Article › peer-review

Abstract

Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticarial reactions, autoimmune diseases, or exposure to medications who develops generalized urticaria lasting more than 24 hours and who was diagnosed with SARS-CoV-2 infection by RT-PCR with a nasopharyngeal swab. We suggest in this patient vasculitic urticaria as a manifestation of SARS-CoV-2 infection.

Original language	English
Pages (from-to)	131-137
Number of pages	7
Journal	Journal of Experimental Biology and Agricultural Sciences
Volume	9
Issue number	2
DOIs	https://doi.org/10.18006/2021.9(2).131.137
State	Published - 2021
Externally published	Yes

Keywords

Autoimmune urticaria
COVID-19
Colombia
SARS-CoV2
Vasculitis

Access to Document

10.18006/2021.9(2).131.137

Cite this

Sepúlveda-Beltran, D., Mondragón-Cardona, A., Conde-Martin, C. E., Lopez-Guevara, O. A., Hernandez-Rojas, N. R., Caviedes-Cleves, M. A., Gutierrez-Ortega, D. E., Rangel-Meza, C. R., Conde-Tavera, F. K., Rodriguez-Morales, A. J., & Dhama, K. (2021). Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia. Journal of Experimental Biology and Agricultural Sciences, 9(2), 131-137. https://doi.org/10.18006/2021.9(2).131.137

@article{c9ec1d95ee7b4645a82693785898edcb,

title = "Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia",

abstract = "Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticarial reactions, autoimmune diseases, or exposure to medications who develops generalized urticaria lasting more than 24 hours and who was diagnosed with SARS-CoV-2 infection by RT-PCR with a nasopharyngeal swab. We suggest in this patient vasculitic urticaria as a manifestation of SARS-CoV-2 infection.",

keywords = "Autoimmune urticaria, COVID-19, Colombia, SARS-CoV2, Vasculitis",

author = "Daniela Sep{\'u}lveda-Beltran and Alvaro Mondrag{\'o}n-Cardona and Conde-Martin, {Carlos Enrique} and Lopez-Guevara, {Oscar Alberto} and Hernandez-Rojas, {Nubia Rocio} and Caviedes-Cleves, {Mario Alberto} and Gutierrez-Ortega, {David E.} and Rangel-Meza, {Carmen R.} and Conde-Tavera, {Franci Karina} and Rodriguez-Morales, {Alfonso J.} and Kuldeep Dhama",

year = "2021",

doi = "10.18006/2021.9(2).131.137",

language = "Ingl{\'e}s",

volume = "9",

pages = "131--137",

journal = "Journal of Experimental Biology and Agricultural Sciences",

issn = "2320-8694",

publisher = "Editorial board of Journal of Experimental Biology and Agricultural Sciences",

number = "2",

}

Sepúlveda-Beltran, D, Mondragón-Cardona, A, Conde-Martin, CE, Lopez-Guevara, OA, Hernandez-Rojas, NR, Caviedes-Cleves, MA, Gutierrez-Ortega, DE, Rangel-Meza, CR, Conde-Tavera, FK, Rodriguez-Morales, AJ & Dhama, K 2021, 'Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia', Journal of Experimental Biology and Agricultural Sciences, vol. 9, no. 2, pp. 131-137. https://doi.org/10.18006/2021.9(2).131.137

Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia. / Sepúlveda-Beltran, Daniela; Mondragón-Cardona, Alvaro; Conde-Martin, Carlos Enrique et al.
In: Journal of Experimental Biology and Agricultural Sciences, Vol. 9, No. 2, 2021, p. 131-137.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection

T2 - A case report in Colombia

AU - Sepúlveda-Beltran, Daniela

AU - Mondragón-Cardona, Alvaro

AU - Conde-Martin, Carlos Enrique

AU - Lopez-Guevara, Oscar Alberto

AU - Hernandez-Rojas, Nubia Rocio

AU - Caviedes-Cleves, Mario Alberto

AU - Gutierrez-Ortega, David E.

AU - Rangel-Meza, Carmen R.

AU - Conde-Tavera, Franci Karina

AU - Rodriguez-Morales, Alfonso J.

AU - Dhama, Kuldeep

PY - 2021

Y1 - 2021

N2 - Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticarial reactions, autoimmune diseases, or exposure to medications who develops generalized urticaria lasting more than 24 hours and who was diagnosed with SARS-CoV-2 infection by RT-PCR with a nasopharyngeal swab. We suggest in this patient vasculitic urticaria as a manifestation of SARS-CoV-2 infection.

AB - Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticarial reactions, autoimmune diseases, or exposure to medications who develops generalized urticaria lasting more than 24 hours and who was diagnosed with SARS-CoV-2 infection by RT-PCR with a nasopharyngeal swab. We suggest in this patient vasculitic urticaria as a manifestation of SARS-CoV-2 infection.

KW - Autoimmune urticaria

KW - COVID-19

KW - Colombia

KW - SARS-CoV2

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=85114329586&partnerID=8YFLogxK

U2 - 10.18006/2021.9(2).131.137

DO - 10.18006/2021.9(2).131.137

M3 - Artículo

AN - SCOPUS:85114329586

SN - 2320-8694

VL - 9

SP - 131

EP - 137

JO - Journal of Experimental Biology and Agricultural Sciences

JF - Journal of Experimental Biology and Agricultural Sciences

IS - 2

ER -

Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this